Evidence map›Paper›PMID 26217965›Full record

ArticleACS chemical neuroscience2015

Structural Modification of the Designer Stimulant α-Pyrrolidinovalerophenone (α-PVP) Influences Potency at Dopamine Transporters.

R Kolanos, F Sakloth, A D Jain, J S Partilla, M H Baumann, R A Glennon

Open access · greenAbstract read
In one paragraph

Article in ACS chemical neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Structure-Activity Relationship ofACS chemical neuroscience · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. An updated review on synthetic cathinones.Archives of toxicology · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Flakka: New Dangerous Synthetic Cathinone on the Drug Scene.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

R KolanosDepartment of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University , 800 East Leigh Street, PO Box 980540, Richmond, Virginia 23298, United States.
F SaklothDepartment of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University , 800 East Leigh Street, PO Box 980540, Richmond, Virginia 23298, United States.
A D JainDepartment of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University , 800 East Leigh Street, PO Box 980540, Richmond, Virginia 23298, United States.
J S PartillaDesigner Drug Research Unit, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health , Baltimore, Maryland 21224, United States.
M H BaumannDesigner Drug Research Unit, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health , Baltimore, Maryland 21224, United States.
R A GlennonDepartment of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University , 800 East Leigh Street, PO Box 980540, Richmond, Virginia 23298, United States.
Virginia Commonwealth University · USNational Institutes of Health · US

Funding

Studies on MDMA and Related CompoundsZIADA000523 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI BAUMANN, MICHAEL · 2009 to 2025
$16.4M
Synthetic cathinones: a new class of illicit drugs affecting DAT & SERTR01DA033930 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI ELTIT, JOSE MIGUEL, GLENNON, RICHARD A · 2012 to 2016
$2.7M
Intramural NIH HHS ZIA DA000523NIDA NIH HHS DA033930NIDA NIH HHS R01 DA033930
6 · The paper itself

Abstract

α-Pyrrolidinovalerophenone (α-PVP, 7) is an illegal synthetic stimulant that is being sold on the clandestine market as "flakka" and "gravel". The potent pharmacological effects of α-PVP are presumably mediated by inhibition of dopamine uptake at the dopamine transporter (DAT). However, little is known about how structural modification of α-PVP influences activity at DAT. Eleven analogs of α-PVP were synthesized and examined for their ability to inhibit uptake of [(3)H]dopamine and [(3)H]serotonin in rat brain synaptosomes. None of the analogs significantly inhibited [(3)H]serotonin uptake when tested at 10 μM at the serotonin transporter (SERT). All of the analogs behaved as DAT reuptake inhibitors, but potencies varied over a >1500-fold range. Potency was primarily associated with the nature of the α-substituent, with the more bulky substituents imparting the highest potency. Expansion of the pyrrolidine ring to a piperidine reduced potency up to 10-fold, whereas conformational constraint in the form of an aminotetralone resulted in the least potent compound. Our study provides the first systematic and comparative structure-activity investigation on the ability of α-PVP analogs to act as inhibitors of DAT.

Indexed as

AnimalsBrainDopamineDopamine Plasma Membrane Transport ProteinsMalePyrrolidinesRatsRats, Sprague-DawleySerotoninSerotonin Plasma Membrane Transport ProteinsTritiumalpha-pyrrolidinovalerophenoneDopamineDopamine Plasma Membrane Transport ProteinsPyrrolidinesSerotoninSerotonin Plasma Membrane Transport ProteinsTritiumDATdopamine transporterflakkaserotonin transporterSERTSynthetic cathinonesα-PBPα-PPPα-PVP

Identifiers

PMID26217965
PMCPMC5349767
OpenAlexW2412911135

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.